{"version":"https://jsonfeed.org/version/1","title":"Pharma Best Practices","home_page_url":"https://pbpw.in","description":"Pharma Best Practices","author":{"name":"Pharma Best Practices"},"items":[{"id":"https://pbpw.in/articles/f/gmp-annex-1-understanding-the-new-pics%E2%80%93ema%E2%80%93who-interpretations","html_content":"<img src=\"https://img1.wsimg.com/isteam/ip/601b454c-97c9-4064-861c-c0f3e5c9181c/Screenshot%202026-10-30%20at%206.21.54%E2%80%AFPM.png\"/><p>Pharma Best Practices | Regulatory and Technical Review | 30 October 2026</p>","url":"https://pbpw.in/articles/f/gmp-annex-1-understanding-the-new-pics%E2%80%93ema%E2%80%93who-interpretations","title":"GMP Annex 1: Understanding the New PIC/S–EMA–WHO Interpretations","summary":"Pharma Best Practices | Regulatory and Technical Review | 30 October 2026","date_modified":"2026-10-31T00:41:13Z"},{"id":"https://pbpw.in/articles/f/us-fda-warning-letters-issued-to-indian-pharma-firms","html_content":"<img src=\"https://img1.wsimg.com/isteam/ip/601b454c-97c9-4064-861c-c0f3e5c9181c/Screenshot%202026-02-17%20at%203.17.08%E2%80%AFPM.png\"/><p>Regulatory Enforcement Analysis: US FDA Warning Letters Issued to Indian Pharmaceutical Entities in 2025</p>","url":"https://pbpw.in/articles/f/us-fda-warning-letters-issued-to-indian-pharma-firms","title":"US FDA Warning Letters Issued to Indian Pharma Firms","summary":"Regulatory Enforcement Analysis: US FDA Warning Letters Issued to Indian Pharmaceutical Entities in 2025","date_modified":"2026-02-17T09:48:41Z"},{"id":"https://pbpw.in/articles/f/engineering-out-contamination","html_content":"<img src=\"https://img1.wsimg.com/isteam/ip/601b454c-97c9-4064-861c-c0f3e5c9181c/Screenshot%202026-02-14%20at%209.49.18%E2%80%AFAM.png\"/><p>Engineering Out Contamination: Design of Premises, Process, and Equipment as CCS Priority as per Annex 1</p>","url":"https://pbpw.in/articles/f/engineering-out-contamination","title":"Engineering Out Contamination","summary":"Engineering Out Contamination: Design of Premises, Process, and Equipment as CCS Priority as per Annex 1","date_modified":"2026-02-14T04:21:02Z"},{"id":"https://pbpw.in/articles/f/how-annex-1-2022-forces-automation-isolators","html_content":"<img src=\"https://img1.wsimg.com/isteam/ip/601b454c-97c9-4064-861c-c0f3e5c9181c/Screenshot%202026-02-11%20at%209.54.42%E2%80%AFAM.png\"/><p>The Silent Mandate: How Annex 1 (2022) Forces Automation and Isolators</p>","url":"https://pbpw.in/articles/f/how-annex-1-2022-forces-automation-isolators","title":"How Annex 1 (2022) Forces Automation &  Isolators","summary":"The Silent Mandate: How Annex 1 (2022) Forces Automation and Isolators","date_modified":"2026-02-11T04:06:37Z"},{"id":"https://pbpw.in/articles/f/control-of-microbiological-contamination","html_content":"<img src=\"https://img1.wsimg.com/isteam/ip/601b454c-97c9-4064-861c-c0f3e5c9181c/Screenshot%202026-02-14%20at%209.35.18%E2%80%AFAM.png\"/><p>Control of Microbiological Contamination : Analysis of FDA Warning Letters Issued to Indian Manufacturers (2022–2025)</p>","url":"https://pbpw.in/articles/f/control-of-microbiological-contamination","title":"Control of Microbiological Contamination ","summary":"Control of Microbiological Contamination : Analysis of FDA Warning Letters Issued to Indian Manufacturers (2022–2025)","date_modified":"2026-02-11T03:42:35Z"},{"id":"https://pbpw.in/articles/f/design-control-of-purified-water-systems","html_content":"<img src=\"https://img1.wsimg.com/isteam/ip/601b454c-97c9-4064-861c-c0f3e5c9181c/Screenshot%202026-02-14%20at%209.38.22%E2%80%AFAM.png\"/><p>Design &amp; Control of Purified Water Systems: A Review of WHO, US FDA &amp; EMA Expectations</p>","url":"https://pbpw.in/articles/f/design-control-of-purified-water-systems","title":"Design & Control of Purified Water Systems","summary":"Design & Control of Purified Water Systems: A Review of WHO, US FDA & EMA Expectations","date_modified":"2026-02-11T03:37:44Z"},{"id":"https://pbpw.in/articles/f/hvac-systems-for-non-sterile-pharmaceutical-manufacturing","html_content":"<img src=\"https://img1.wsimg.com/isteam/ip/601b454c-97c9-4064-861c-c0f3e5c9181c/Screenshot%202026-02-14%20at%209.40.35%E2%80%AFAM.png\"/><p>HVAC Systems for Non-Sterile Pharmaceutical Manufacturing: A Comparative Study of WHO, US FDA, and EMA Framework</p>","url":"https://pbpw.in/articles/f/hvac-systems-for-non-sterile-pharmaceutical-manufacturing","title":"HVAC Systems for Non-Sterile Pharmaceutical Manufacturing","summary":"HVAC Systems for Non-Sterile Pharmaceutical Manufacturing: A Comparative Study of WHO, US FDA, and EMA Framework","date_modified":"2026-02-09T02:37:43Z"}]}